دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
New avenues in the prevention of sudden cardiac death
Filippo Crea
doi : 10.1093/eurheartj/ehac277
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2083–2086
Current clinical data and experience of TAVR in China
Yaling Han
doi : 10.1093/eurheartj/ehab821
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2087–2088
Building a digital future together
Mark Nicholls
doi : 10.1093/eurheartj/ehac018
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2089–2091
Not only lungs: COVID-19 hits platelets as well
Dario Bongiovanni, Melissa Klug, Marco Valgimigli, Isabell Bernlochner
doi : 10.1093/eurheartj/ehac076
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2092–2093
Increased risk of incident diabetes in patients with long COVID
Francesco Paneni, Carlo Patrono
doi : 10.1093/eurheartj/ehac196
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2094–2095
Cardiac sympathetic denervation in the prevention of genetically mediated life-threatening ventricular arrhythmias
Peter J. Schwartz, Michael J. Ackerman
doi : 10.1093/eurheartj/ehac134
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2096–2102
Proper management of patients affected by genetic disorders causing life-threatening arrhythmias is important for several reasons, including even societal ones, given the predominantly young age of those affected.
Sudden cardiac death in congenital heart disease
Paul Khairy, Michael J Silka, Jeremy P Moore, James A DiNardo, Jim T Vehmeijer, Mary N Sheppard, Alexander van de Bruaene, Marie-A Chaix, Margarita Brida, Benjamin M Moore, Maully J Shah, Blandine Mondésert, Seshadri Balaji, Michael A Gatzoulis, Magalie Ladouceur
doi : 10.1093/eurheartj/ehac104
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2103–2115
Sudden cardiac death (SCD) accounts for up to 25% of deaths in patients with congenital heart disease (CHD). To date, research has largely been driven by observational studies and real-world experience.
Early and late-onset syncope: insight into mechanisms
Parisa Torabi, Giulia Rivasi, Viktor Hamrefors, Andrea Ungar, Richard Sutton, Michele Brignole, Artur Fedorowski
doi : 10.1093/eurheartj/ehac017
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2116–2123
Age at first syncope: a consideration for assessing probable cause?
Shaun Colburn, David G. Benditt
doi : 10.1093/eurheartj/ehac122
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2124–2126
Silent brain infarcts impact on cognitive function in atrial fibrillation
Michael Kühne, Philipp Krisai, Michael Coslovsky, Nicolas Rodondi, Andreas Müller, Jürg H Beer, Peter Ammann, Angelo Auricchio, Giorgio Moschovitis, Daniel Hayoz, Richard Kobza, Dipen Shah, Frank Peter Stephan, Jürg Schläpfer, Marcello Di Valentino, Stefanie Aeschbacher, Georg Ehret, Ceylan Eken, Andreas Monsch, Laurent Roten, Matthias Schwenkglenks, Anne Springer, Christian Sticherling, Tobias Reichlin, Christine S Zuern, Pascal B Meyre, Steffen Blum, Tim Sinnecker, Jens Würfel, Leo H. Bonati, David Conen, Stefan Osswald, for the Swiss-AF Investigators
doi : 10.1093/eurheartj/ehac020
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2127–2135
We aimed to investigate the association of clinically overt and silent brain lesions with cognitive function in atrial fibrillation (AF) patients.
Clinical strokes in atrial fibrillation: the tip of the iceberg
T Jared Bunch, Benjamin A Steinberg
doi : 10.1093/eurheartj/ehab900
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2136–2138
Biological substrate modification suppresses ventricular arrhythmias in a porcine model of chronic ischaemic cardiomyopathy
James F. Dawkins, Ashkan Ehdaie, Russell Rogers, Daniel Soetkamp, Jackelyn Valle, Kevin Holm, Lizbeth Sanchez, Ileana Tremmel, Asma Nawaz, Michael Shehata, Xunzhang Wang, Adityo Prakosa, Joseph Yu, Jennifer E Van Eyk, Natalia Trayanova, Eduardo Marbán, Eugenio Cingolani
doi : 10.1093/eurheartj/ehac042
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2139–2156
Cardiomyopathy patients are prone to ventricular arrhythmias (VA) and sudden cardiac death. Current therapies to prevent VA include radiofrequency ablation to destroy slowly conducting pathways of viable myocardium which support re-entry. Here, we tested the reverse concept, namely that boosting local tissue viability in zones of slow conduction might eliminate slow conduction and suppress VA in ischaemic cardiomyopathy.
A novel exosome-based therapy for post-MI arrhythmias
Marine Cacheux, Fadi G Akar
doi : 10.1093/eurheartj/ehac155
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2157–2159
Ablate and pace for patients with atrial fibrillation: a fragile option?
Hargun Kaur, William F McIntyre, Emilie P Belley-Côté
doi : 10.1093/eurheartj/ehac091
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Page 2160
Is APAF-CRT robust enough to change clinical practice?
Michele Brignole, Davide Soranna, Michiel Rienstra
doi : 10.1093/eurheartj/ehac092
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Pages 2161–2162
Double aortic arch with aortic arch diverticulum leading to the use of tracheal intubation in a newborn
Jian Zhu, Jia-Ni Zou, Shui-Bo Zhu, Er-Ping Xi
doi : 10.1093/eurheartj/ehac174
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Page 2163
Transcatheter closure of a rare ruptured giant non-coronary Valsalva sinus aneurysm
Qun-shan Shen, Xiao-xian Deng, Chi Jing, Yun-yan Li
doi : 10.1093/eurheartj/ehac177
European Heart Journal, Volume 43, Issue 22, 7 June 2022, Page 2164
